Verastem Inc (VSTM)
$2.55
0.06 (2.30%)
VSTM Stock Quote Delayed 30 Minutes
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
460.93M
PE Ratio
-11.09
EPS
-0.23
Volume (Avg. Vol.)
1.46M
Day's Range
2.53 - 2.62
52-Week Range
1.14 - 4.94
Dividend & Yield
N/A (N/A)
VSTM Stock Predictions, Articles, and Verastem Inc News
3 Stocks to Watch on Friday: DDR Corp (DDR), Hess Corp. (HES) and Verastem Inc (VSTM)
DDR (DDR) to spin off 50 properties, Hess (HES) to dethrone John Hess as CEO and Verastem (VSTM) announces $25 million common share offering.
24 Biotechnology Stocks to Sell Now
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
32 Biotechnology Stocks to Sell Now
This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Biotechnology Stocks to Sell Now
This week, the overall grades of 11 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
8 Biotechnology Stocks to Sell Now
This week, the overall grades of eight biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The overall ratings of nine biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of nine biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of 10 biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
The ratings of 10 biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Biotechnology Stocks to Sell Now
This week, the ratings of 11 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
13 Biotechnology Stocks to Sell Now
This week, the ratings of 13 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
